WO2003045350A2 - Dispositif pour introduire des substances - Google Patents

Dispositif pour introduire des substances Download PDF

Info

Publication number
WO2003045350A2
WO2003045350A2 PCT/AT2002/000332 AT0200332W WO03045350A2 WO 2003045350 A2 WO2003045350 A2 WO 2003045350A2 AT 0200332 W AT0200332 W AT 0200332W WO 03045350 A2 WO03045350 A2 WO 03045350A2
Authority
WO
WIPO (PCT)
Prior art keywords
sea sponge
sea
substance
sponge
substances
Prior art date
Application number
PCT/AT2002/000332
Other languages
German (de)
English (en)
Other versions
WO2003045350A3 (fr
Inventor
Wolfgang Knogler
Original Assignee
Wolfgang Knogler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wolfgang Knogler filed Critical Wolfgang Knogler
Priority to AU2002358400A priority Critical patent/AU2002358400A1/en
Publication of WO2003045350A2 publication Critical patent/WO2003045350A2/fr
Publication of WO2003045350A3 publication Critical patent/WO2003045350A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants

Definitions

  • the invention relates to a device for introducing substances, such as medicaments, which are in liquid, spray, ointment or gel consistency, the absorption of the substance taking place through the skin
  • DE 35 90 580 C1 discloses an intravaginally positionable contraceptive device.
  • This device comprises an essentially cylindrical block made of plastic, which is impregnated with a medicament, as an elastic support body.
  • This support body is provided with an opening which runs concentrically to the cylinder axis, this opening being formed in a blind hole shape.
  • a driver is arranged in this opening and is connected to the support body by anchoring elements by a foaming process.
  • the object of the invention is to provide a device of the type mentioned at the outset, which, with a non-operative treatment, enables the introduction of appropriate medication for alleviating or curing ailments in a targeted manner for the causes of the ailments.
  • the device according to the invention is characterized in that a sea sponge is provided as a carrier for the substance to be introduced.
  • a sea sponge is provided as a carrier for the substance to be introduced.
  • the sea sponge is in contact with a mucous membrane and / or skin, preferably in an opening in the body, in particular in the urogenital and / or vaginal and / or anal tract and / or in the mouth and / or in the ears - And / or is arranged in the nasal cavity. Due to the effect of the substances, in particular the medication and the sensitivity of the skin or mucous membranes, there is the possibility of a promising treatment, which may prevent an operation. Another advantage of the invention is that the treatment can be carried out without interrupting the daily routine, since the device according to the invention can be worn in the body opening and does not require any external devices during the treatment. Furthermore, the use of a sea sponge offers the advantage that the sponge has high and extensive contact with, for example, the vaginal mucosa.
  • the sea sponge for absorbing the substance to be introduced, in particular a medicament is impregnated and / or provided with the substance to be used in a defined manner.
  • the further serious advantage must also be shown namely, that the use of a sea sponge as a carrier for substances not only provides protection against contraception, if necessary, but the sea sponge itself takes on this task. In this way, even a coitus with inserto of the sea sponge is advantageously possible.
  • the sea sponge has a diameter of 1 to 70 mm, preferably 25 to 35 mm.
  • the sea sponge covers the outer cervical opening. This is practically a tamponade of the back
  • Vaginal vault (formix vagine). This tamponade effect in the individual sections of the vagina also provides a treatment device for incontinence, since the ring muscles of the vagina are stimulated to permanent contraction.
  • the sea sponge is natural and in particular fine-pored and soft. This makes the sea sponge an ideal substance carrier with the greatest body tolerance.
  • the substance to be introduced is, for example, an antibiotic, an antimycotic, a vaginal disinfectant, a contraceptive, a nutrient solution or the like.
  • an antibiotic for example, an antibiotic, an antimycotic, a vaginal disinfectant, a contraceptive, a nutrient solution or the like.
  • the preparations or the parameters can be tailored to the individual needs of the patient or of the patient or the treatment plan can be adjusted or changed.
  • the sea sponge is impregnated with flavorings and / or natural substances, such as, for example, olive oil, soap solutions or surfactants. You can also use it Various parameters of the treatment can be changed in the simplest form in order to achieve a good healing result. Furthermore, irritation of the skin or mucous membrane can also be avoided.
  • Another advantage of the use of the sea sponge according to the invention in the vaginal tract is that its use in this area results in a reduction in the vaginal tube, which leads to an increased stretching stimulus during coitus. This enables increased and faster pleasure.
  • the sea sponge is surrounded by a net, the net being provided with a thread. This makes removal easy and unproblematic.
  • the sea sponge can be used in a preferably cylindrical shape in the case of bleeding as a biological tampon.
  • the advantage lies in the fact that necrosis, as well as substances that have been implanted with bacteria, i.e. body fluids, are excreted in the course of the bleeding, which are used biologically differently by the sea sponge eo ipse than is possible with a tampon consisting of artificial material.
  • the sea sponge according to the invention has the particular advantage that it is well tolerated as a bio product for all skin types or types, in particular for the mucous membranes. Furthermore, sea sponges have the serious advantage that, even if they serve as a carrier for substances to be introduced, they have a shaping consistency that is retained over a long period of time and is not technically limited in time due to its biological qualities and elasticity. Due to their specific morphological structure, sea sponges offer an optimal carrier for other substances to be introduced into the human body. It is also an advantage here that the biodiversity, especially the sea sponges, is incredibly large compared to the natural sponges in the tropical rainforests.
  • the sea sponges alone represent archaic reserves for their use and / or for the extraction of substances that come from terrestrial organisms.
  • these substances are essentially chemotherapeutic, anti-inflammatory or antiviral due to their pharmacological potential - often also in cooperation with them.
  • Eleuthrobin has the same
  • Sea sponges are also reservoirs of countless marine microorganisms that have been washed in or sedimented.
  • An example of this would be bryostatin, which is contained in sea sponges. Bryostatin inhibits protein kinase C.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne un dispositif pour introduire des substances, par exemple des médicaments, sous forme de liquide, pulvérisation, pâte ou gel. La résorption de la substance s'effectue à travers la peau. Une éponge marine sert de substrat pour la substance à introduire.
PCT/AT2002/000332 2001-11-28 2002-11-28 Dispositif pour introduire des substances WO2003045350A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002358400A AU2002358400A1 (en) 2001-11-28 2002-11-28 Device for incorporating substances which contain a sea sponge as a support

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT18602001 2001-11-28
ATA1860/01 2001-11-28

Publications (2)

Publication Number Publication Date
WO2003045350A2 true WO2003045350A2 (fr) 2003-06-05
WO2003045350A3 WO2003045350A3 (fr) 2004-03-11

Family

ID=3689153

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AT2002/000332 WO2003045350A2 (fr) 2001-11-28 2002-11-28 Dispositif pour introduire des substances

Country Status (2)

Country Link
AU (1) AU2002358400A1 (fr)
WO (1) WO2003045350A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2943979A (en) * 1959-06-23 1960-07-05 Nathaniel M Elias Concentrated foam-producing spermicides
GB1067505A (en) * 1964-05-20 1967-05-03 Univ Sydney Improvements relating to the administration of medicaments and the like

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2943979A (en) * 1959-06-23 1960-07-05 Nathaniel M Elias Concentrated foam-producing spermicides
GB1067505A (en) * 1964-05-20 1967-05-03 Univ Sydney Improvements relating to the administration of medicaments and the like

Also Published As

Publication number Publication date
AU2002358400A8 (en) 2003-06-10
AU2002358400A1 (en) 2003-06-10
WO2003045350A3 (fr) 2004-03-11

Similar Documents

Publication Publication Date Title
DE69532166T2 (de) Mikrokatheter
DE69127342T2 (de) Behandlungssystem durch Iontophorese
DE602004013027T2 (de) Gerät und verfahren zur verabreichung eines therapeutischen mittels
DE69937564T2 (de) Prostata- formulierung
DE69935155T2 (de) Gesteuertes freisetzungssystem zur abgabe von therapeutika in den innenohrkanal
EP0741587B1 (fr) Systeme de dosage pouvant etre implante
EP2919846B1 (fr) Cathéter, en particulier destiné au traitement de la prostate et/ou de la vessie, et kit contenant ce cathéter
WO2015176778A1 (fr) Dispositif multicanaux de fourniture de courant continu utilisable à des fins thérapeutiques
DE102011119160A1 (de) Vorrichtung zum Verhindern und/oder Behandeln von Harnwegsinfektionen
DE69305194T2 (de) Intrauterine und/oder intravaginale Vorrichtung
WO2003045350A2 (fr) Dispositif pour introduire des substances
AT6723U2 (de) Einrichtung zum einbringen von stoffen
DE19544255A1 (de) Verbandsmaterial
WO2010111988A1 (fr) Dispositif de traitement du pénis par allongement, champ magnétique et principe actif
DE102014012206A1 (de) Arzneimittelträger zum Behandeln und Vorbeugen von krankhaften Zuständen im urogenitalen Raum
DE2140557A1 (de) Heilmittelabgabetablette fuer einen menschlichen augapfel
DE102019128955B4 (de) Einrichtung zur Behandlung von Erkrankungen im Analbereich
DE19535643C2 (de) Medizinischer Kühlkompressenverband zur Erstversorgung und Nachbehandlung von Muskel- und Gelenkverletzungen
EP1669064A1 (fr) Composition et méthode d'une thérapie topique de la néurodermite
Imhäuser Der psychogene Klumpfuß
EP3183025B1 (fr) Support de médicament pour le traitement et la prévention d'états pathologiques de l'appareil urogénital
EP4101423A1 (fr) Dispositif de traitement d'un organisme contre les troubles pondéraux
EP3811915A1 (fr) Corps composite, utilisation d'un corps composite et ensemble avec les composants d'une pluralité de corps composites
AT500485B1 (de) Anordnung zur keimreduktion bzw. -abtötung in körperhöhlen
Mattmann-Allamand Indirekter Wirksamkeitsnachweis durch den Vergleich ganzer Therapiesysteme ohne Placebo-Gruppen

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP